Effect of azelnidipine and amlodipine on single cell mechanics in mouse cardiomyocytes

Gentaro Iribe, Keiko Kaihara, Hiroshi Itoh, Keiji Naruse

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Azelnidipine and amlodipine are dihydropyridine-type Ca2+ channel blockers for the treatment of hypertension. Although these drugs have high vasoselectivity and small negative inotropic effects in vivo, little is known regarding their direct effects on cellular contractility without humoral regulation or the additive effects of these drugs with other antihypertensive drugs on myocardial contractility. To investigate the effects of Ca2+ channel blockers on single cell mechanics, mouse cardiomyocytes were enzymatically isolated, and a pair of carbon fibers was attached to opposite cell-ends to stretch the cells. Cells were paced at 4 Hz superfused in normal Tyrode solution at 37 1C. Cell length and active/passive force calculated from carbon fiber bending were recorded in 6 different preload conditions. Slopes of end-systolic force - length relation curves (maximum elastance) were measured as an index of contractility before and after drugs were administered. Azelnidipine at 10 nM and 100 nM did not change maximum elastance, while amlodipine at 100 nM did decrease maximum elastance. The combination of RNH-6270 (active form of angiotensin II receptor blocker, olmesartan, 10 nM) and either amlodipine (10 nM) or azelnidipine (10 nM) did not affect maximum elastance. Although both amlodipine and azelnidipine can be used safely at therapeutically relevant concentrations even in combination with olmesartan, the present results suggest that azelnidipine has a less negative inotropic action compared to amlodipine.

Original languageEnglish
Pages (from-to)142-146
Number of pages5
JournalEuropean Journal of Pharmacology
Volume715
Issue number1-3
DOIs
Publication statusPublished - 2013

Fingerprint

Amlodipine
Mechanics
Cardiac Myocytes
Pharmaceutical Preparations
Angiotensin Receptor Antagonists
Antihypertensive Agents
azelnidipine
Hypertension
olmesartan

Keywords

  • Carbon fiber
  • Force - length relation
  • Maximum elastance
  • Stretch

ASJC Scopus subject areas

  • Pharmacology

Cite this

Effect of azelnidipine and amlodipine on single cell mechanics in mouse cardiomyocytes. / Iribe, Gentaro; Kaihara, Keiko; Itoh, Hiroshi; Naruse, Keiji.

In: European Journal of Pharmacology, Vol. 715, No. 1-3, 2013, p. 142-146.

Research output: Contribution to journalArticle

@article{bd950db527764321bb445642d16ed541,
title = "Effect of azelnidipine and amlodipine on single cell mechanics in mouse cardiomyocytes",
abstract = "Azelnidipine and amlodipine are dihydropyridine-type Ca2+ channel blockers for the treatment of hypertension. Although these drugs have high vasoselectivity and small negative inotropic effects in vivo, little is known regarding their direct effects on cellular contractility without humoral regulation or the additive effects of these drugs with other antihypertensive drugs on myocardial contractility. To investigate the effects of Ca2+ channel blockers on single cell mechanics, mouse cardiomyocytes were enzymatically isolated, and a pair of carbon fibers was attached to opposite cell-ends to stretch the cells. Cells were paced at 4 Hz superfused in normal Tyrode solution at 37 1C. Cell length and active/passive force calculated from carbon fiber bending were recorded in 6 different preload conditions. Slopes of end-systolic force - length relation curves (maximum elastance) were measured as an index of contractility before and after drugs were administered. Azelnidipine at 10 nM and 100 nM did not change maximum elastance, while amlodipine at 100 nM did decrease maximum elastance. The combination of RNH-6270 (active form of angiotensin II receptor blocker, olmesartan, 10 nM) and either amlodipine (10 nM) or azelnidipine (10 nM) did not affect maximum elastance. Although both amlodipine and azelnidipine can be used safely at therapeutically relevant concentrations even in combination with olmesartan, the present results suggest that azelnidipine has a less negative inotropic action compared to amlodipine.",
keywords = "Carbon fiber, Force - length relation, Maximum elastance, Stretch",
author = "Gentaro Iribe and Keiko Kaihara and Hiroshi Itoh and Keiji Naruse",
year = "2013",
doi = "10.1016/j.ejphar.2013.05.030",
language = "English",
volume = "715",
pages = "142--146",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - Effect of azelnidipine and amlodipine on single cell mechanics in mouse cardiomyocytes

AU - Iribe, Gentaro

AU - Kaihara, Keiko

AU - Itoh, Hiroshi

AU - Naruse, Keiji

PY - 2013

Y1 - 2013

N2 - Azelnidipine and amlodipine are dihydropyridine-type Ca2+ channel blockers for the treatment of hypertension. Although these drugs have high vasoselectivity and small negative inotropic effects in vivo, little is known regarding their direct effects on cellular contractility without humoral regulation or the additive effects of these drugs with other antihypertensive drugs on myocardial contractility. To investigate the effects of Ca2+ channel blockers on single cell mechanics, mouse cardiomyocytes were enzymatically isolated, and a pair of carbon fibers was attached to opposite cell-ends to stretch the cells. Cells were paced at 4 Hz superfused in normal Tyrode solution at 37 1C. Cell length and active/passive force calculated from carbon fiber bending were recorded in 6 different preload conditions. Slopes of end-systolic force - length relation curves (maximum elastance) were measured as an index of contractility before and after drugs were administered. Azelnidipine at 10 nM and 100 nM did not change maximum elastance, while amlodipine at 100 nM did decrease maximum elastance. The combination of RNH-6270 (active form of angiotensin II receptor blocker, olmesartan, 10 nM) and either amlodipine (10 nM) or azelnidipine (10 nM) did not affect maximum elastance. Although both amlodipine and azelnidipine can be used safely at therapeutically relevant concentrations even in combination with olmesartan, the present results suggest that azelnidipine has a less negative inotropic action compared to amlodipine.

AB - Azelnidipine and amlodipine are dihydropyridine-type Ca2+ channel blockers for the treatment of hypertension. Although these drugs have high vasoselectivity and small negative inotropic effects in vivo, little is known regarding their direct effects on cellular contractility without humoral regulation or the additive effects of these drugs with other antihypertensive drugs on myocardial contractility. To investigate the effects of Ca2+ channel blockers on single cell mechanics, mouse cardiomyocytes were enzymatically isolated, and a pair of carbon fibers was attached to opposite cell-ends to stretch the cells. Cells were paced at 4 Hz superfused in normal Tyrode solution at 37 1C. Cell length and active/passive force calculated from carbon fiber bending were recorded in 6 different preload conditions. Slopes of end-systolic force - length relation curves (maximum elastance) were measured as an index of contractility before and after drugs were administered. Azelnidipine at 10 nM and 100 nM did not change maximum elastance, while amlodipine at 100 nM did decrease maximum elastance. The combination of RNH-6270 (active form of angiotensin II receptor blocker, olmesartan, 10 nM) and either amlodipine (10 nM) or azelnidipine (10 nM) did not affect maximum elastance. Although both amlodipine and azelnidipine can be used safely at therapeutically relevant concentrations even in combination with olmesartan, the present results suggest that azelnidipine has a less negative inotropic action compared to amlodipine.

KW - Carbon fiber

KW - Force - length relation

KW - Maximum elastance

KW - Stretch

UR - http://www.scopus.com/inward/record.url?scp=84885482220&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885482220&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2013.05.030

DO - 10.1016/j.ejphar.2013.05.030

M3 - Article

C2 - 23747592

AN - SCOPUS:84885482220

VL - 715

SP - 142

EP - 146

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1-3

ER -